This article first appeared on GuruFocus.

Tango Therapeutics Inc (NASDAQ:TNGX) is set to release its Q3 2025 earnings on Nov 4, 2025. The consensus estimate for Q3 2025 revenue is $37.14 million, and the earnings are expected to come in at -$0.05 per share. The full year 2025's revenue is expected to be $49.66 million and the earnings are expected to be -$1.09 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 5 Warning Signs with TNGX.

Is TNGX fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for Tango Therapeutics Inc (NASDAQ:TNGX) have increased from $28.43 million to $49.66 million for the full year 2025. However, for 2026, they have declined from $25.77 million to $13.97 million over the past 90 days. Earnings estimates for the full year 2025 have improved from -$1.39 per share to -$1.09 per share. For 2026, earnings estimates have slightly increased from -$1.35 per share to -$1.34 per share over the past 90 days.

In the previous quarter ending 2025-06-30, Tango Therapeutics Inc's (NASDAQ:TNGX) actual revenue was $3.18 million, which missed analysts' revenue expectations of $6.68 million by -52.37%. Tango Therapeutics Inc's (NASDAQ:TNGX) actual earnings were -$0.35 per share, which beat analysts' earnings expectations of -$0.36 per share by 3.85%. After releasing the results, Tango Therapeutics Inc (NASDAQ:TNGX) was up by 4.86% in one day.

Based on the one-year price targets offered by 8 analysts, the average target price for Tango Therapeutics Inc (NASDAQ:TNGX) is $12.13 with a high estimate of $15.00 and a low estimate of $8.00. The average target implies an upside of 49.51% from the current price of $8.11.

Based on GuruFocus estimates, the estimated GF Value for Tango Therapeutics Inc (NASDAQ:TNGX) in one year is $2.78, suggesting a downside of -65.72% from the current price of $8.11.

Based on the consensus recommendation from 9 brokerage firms, Tango Therapeutics Inc's (NASDAQ:TNGX) average brokerage recommendation is currently 1.6, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.